当前位置:首页 - 行情中心 - 诺诚健华-U(688428) - 财务分析 - 利润表

诺诚健华-U

(688428)

  

流通市值:32.35亿  总市值:214.15亿
流通股本:2.66亿   总股本:17.63亿

利润表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、营业总收入697,748,228.93419,737,910.92165,824,020.34738,537,047.65
营业收入697,748,228.93419,737,910.92165,824,020.34738,537,047.65
二、营业总成本975,965,605.67679,410,003.05303,015,436.111,377,500,498.7
营业成本98,028,598.0260,139,759.0324,290,417.68128,435,146.12
税金及附加10,737,102.166,641,312.433,036,877.519,704,437.23
销售费用273,927,859.06157,153,114.3389,533,244.9366,891,163.84
管理费用125,820,073.2984,975,021.742,408,649.62184,122,329.22
研发费用614,983,375.71421,404,233.69177,728,720.87757,253,137.36
财务费用-147,531,402.57-50,903,438.13-33,982,474.47-68,905,715.07
其中:利息费用20,557,333.1610,471,937.885,177,359.3935,211,746.71
其中:利息收入138,559,308.8494,559,141.3947,128,560.55192,333,014.71
加:公允价值变动收益-29,423,716.12-23,256,781.3-16,476,486.81-53,962,753.45
加:投资收益3,091,034.65-932,689.31-1,339,525.495,571,778.88
信用减值损失(新)-683,961.47-668,422.46--268,084.48
其他收益19,951,442.3316,614,129.59,316,072.3936,468,381.57
营业利润平衡项目0000
四、营业利润-285,282,577.35-267,915,855.7-145,691,355.68-651,154,128.53
加:营业外收入47,821.1246,721.1231,000.111,782,249
减:营业外支出54,408.1154,343.66-4,833,746.92
利润总额平衡项目0000
五、利润总额-285,289,164.34-267,923,478.24-145,660,355.58-644,205,626.45
减:所得税费用28,419.728,449.720.11,425,960.95
六、净利润-285,317,584.04-267,951,927.94-145,660,375.68-645,631,587.4
持续经营净利润-285,317,584.04-267,951,927.94-145,660,375.68-645,631,587.4
归属于母公司股东的净利润-275,409,931.99-261,840,060.1-142,403,395.72-631,262,907.71
少数股东损益-9,907,652.05-6,111,867.84-3,256,979.96-14,368,679.69
(一)基本每股收益-0.16-0.16-0.08-0.37
(二)稀释每股收益-0.16-0.16-0.08-0.37
八、其他综合收益-61,320,760.9536,330,518.7510,452,098.53113,543,810.79
归属于母公司股东的其他综合收益-61,320,760.9536,330,518.7510,452,098.53113,543,810.79
九、综合收益总额-346,638,344.99-231,621,409.19-135,208,277.15-532,087,776.61
归属于母公司股东的综合收益总额-336,730,692.94-225,509,541.35-131,951,297.19-517,719,096.92
归属于少数股东的综合收益总额-9,907,652.05-6,111,867.84-3,256,979.96-14,368,679.69
公告日期2024-11-122024-08-212024-05-142024-03-29
审计意见(境内)标准无保留意见
TOP↑